"Risa;Okazaki|Kunihisa;Kamikawa|Hideki;Uno|Hiroto;Okuda|Shihoko;Namba|Mitsunobu;Kano|Mizuki;Morita|","Assessing the Proportion of Clinical Trial Eligibility Criteria Expressible with Standard EHR Data Elements","MEDINFO 2025 ? Healthcare Smart ~ Medicine Deep","0926-9630","2025-08-07","","","1892","1893","isVersionOf https://doi.org/10.3233/shti251267","40776284","","http://escholarship.lib.okayama-u.ac.jp/69113","10.3233/shti251267" "Mizuki;Morita|Mina;Honjoh|Takahiro;Yamane|","Trend of Digital Biomarkers (dBM) as Endpoints in Clinical Trials: Secondary Analysis of Open Data","MEDINFO 2025 ? Healthcare Smart ~ Medicine Deep","0926-9630","2025-08-07","","","391","395","isVersionOf https://doi.org/10.3233/shti250868","","","http://escholarship.lib.okayama-u.ac.jp/69099","10.3233/shti250868" "Yusuke;Fukui|Koh;Tadokoro|Minaki;Hamada|Kyoichi;Asada|Lyang-Ja;Lee|Hidehisa;Tachiki|Ryuta;Morihara|Koji;Abe|Toru;Yamashita|","A Novel Peptidome Technology for the Diagnosis of Mild Cognitive Impairment and Alzheimerfs Disease by Selected Reaction Monitoring","Journal of Alzheimer's Disease","1387-2877","2024-06-25","100","1","219","228","isVersionOf https://doi.org/10.3233/jad-230915","38848173","001265662600015","http://escholarship.lib.okayama-u.ac.jp/67496","10.3233/jad-230915" "Zhihong;Bian|Xinran;Hu|Xia;Liu|Haibo;Yu|Yuting;Bian|Hongming;Sun|Yusuke;Fukui|Ryuta;Morihara|Hiroyuki;Ishiura|Toru;Yamashita|","Protective Effects of Rivaroxaban on White Matter Integrity and Remyelination in a Mouse Model of Alzheimerfs Disease Combined with Cerebral Hypoperfusion","Journal of Alzheimer's Disease","1387-2877","2023-11-07","96","2","609","622","isVersionOf https://doi.org/10.3233/jad-230413","37840489","001099536400015","http://escholarship.lib.okayama-u.ac.jp/66204","10.3233/jad-230413" "Zhihong;Bian|Xia;Liu|Tian;Feng|Haibo;Yu|Xiao;Hu|Xinran;Hu|Yuting;Bian|Hongming;Sun|Koh;Tadokoro|Mami;Takemoto|Taijun;Yunoki|Yumiko;Nakano|Yusuke;Fukui|Ryuta;Morihara|Koji;Abe|Toru;Yamashita|","Protective Effect of Rivaroxaban Against Amyloid Pathology and Neuroinflammation Through Inhibiting PAR-1 and PAR-2 in Alzheimerfs Disease Mice","Journal of Alzheimer's Disease","1387-2877","2022-3-8","86","1","111","123","isVersionOf https://doi.org/10.3233/jad-215318","35001892","000768536700003","http://escholarship.lib.okayama-u.ac.jp/63377","10.3233/jad-215318" "Xiaowen ;Shi|Xia;Liu|Jingwei;Shang|Ryuta;Morihara|Yumiko;Nakano|Tian;Feng|Yong;Huang|Kota;Sato|Mami;Takemoto|Nozomi;Hishikawa|Toru;Yamashita|Koji;Abe|","Acute Anti-Inflammatory Markers ITIH4 and AHSG in Mice Brain of a Novel Alzheimer's Disease Model","Journal of Alzheimer's Disease","1387-2877","2019-04-23","68","4","1667","1675","isVersionOf https://doi.org/10.3233/JAD-181218","30958362","000465612500029","https://ousar.lib.okayama-u.ac.jp/57755","10.3233/JAD-181218" "Tian;Feng|Toru;Yamashita|Jingwei;Shang|Xiaowen;Shi|Yumiko;Nakano|Ryuta;Morihara|Keiichiro;Tsunoda|Emi;Nomura|Ryo;Sasaki|Koh;Tadokoro|Namiko;Matsumoto|Nozomi;Hishikawa|Yasuyuki;Ohta|Koji;Abe|","Clinical and Pathological Benefits of Edaravone for Alzheimer's Disease with Chronic Cerebral Hypoperfusion in a Novel Mouse Model","Journal of Alzheimer's Disease","1387-2877","2019-09-03","71","1","327","339","isVersionOf https://doi.org/10.3233/JAD-190369","31403949","000484216500026","https://ousar.lib.okayama-u.ac.jp/57753","10.3233/JAD-190369"